The use of reTURB in T1 bladder cancer: a Norwegian population-based study

References

• Babjuk M, Burger M, Comperat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019;76(5):639–657.
   PubMed Web of Science ®Google Scholar
• Herr HW, Donat SM. Quality control in transurethral resection of bladder tumours. BJU Int. 2008;102(9 Pt B):1242–1246.
   PubMed Web of Science ®Google Scholar
• Dutta SC, Smith JA Jr, Shappell SB, et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol. 2001;166(2):490–493.
   PubMed Web of Science ®Google Scholar
• Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843–849.
   PubMed Web of Science ®Google Scholar
• Soria F, Marra G, D’Andrea D, et al. The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer. Transl Androl Urol. 2019;8(1):46–53.
   PubMed Web of Science ®Google Scholar
• Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol. 1999;162(1):74–76.
   PubMed Web of Science ®Google Scholar
• Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol. 2018;73(6):925–933.
   PubMed Web of Science ®Google Scholar
• Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2008;54(2):303–314.
   PubMed Web of Science ®Google Scholar
• Mostafid H, Brausi M. Measuring and improving the quality of transurethral resection for bladder tumour (TURBT). BJU Int. 2012;109(11):1579–1582.
   PubMed Web of Science ®Google Scholar
• Chang SS, Boorjian SA, Chou R, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196(4):1021–1029.
   PubMed Web of Science ®Google Scholar
• Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer (Oxford, England: 1990). 2009;45(7):1218–1231.
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol. 2004;46(2):170–176.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998;22(12):1435–1448.
   PubMed Web of Science ®Google Scholar
• Crowther MJ, Lambert PC. A general framework for parametric survival analysis. Statist Med. 2014;33(30):5280–5297.
   PubMed Web of Science ®Google Scholar
• Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2):265–290.
   Web of Science ®Google Scholar
• Patschan O, Holmang S, Hosseini A, et al. Second-look resection for primary stage T1 bladder cancer: a population-based study. Scand J Urol. 2017;51(4):301–307.
   PubMed Web of Science ®Google Scholar
• Gontero P, Sylvester R, Pisano F, et al. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guerin. BJU Int. 2016;118(1):44–52.
   PubMed Web of Science ®Google Scholar
• Nieder AM, Meinbach DS, Kim SS, et al. Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol. 2005;174(6):2307–2309.
   PubMed Web of Science ®Google Scholar
• Divrik RT, Sahin AF, Yildirim U, et al. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol. 2010;58(2):185–190.
   PubMed Web of Science ®Google Scholar
• Palou J, Pisano F, Sylvester R, et al. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World J Urol. 2018;36(10):1621–1627.
   PubMed Web of Science ®Google Scholar
• Herr HW, Donat SM. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Iin. 2006;97(6):1194–1198.
   PubMed Web of Science ®Google Scholar
• Bishr M, Lattouf JB, Latour M, et al. Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer. CUAJ. 2014;8(5–6):306–310.
   Google Scholar
• Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41(5):523–531.
   PubMed Web of Science ®Google Scholar
• Jancke G, Rosell J, Jahnson S. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer. Scand J Urol. 2014;48(3):276–283.
   PubMed Web of Science ®Google Scholar
• Blindheim A, Fosså S, Babigumira R, et al. T1 bladder cancer in Norway: treatment and survival. Scand J Urol. 2020;12:1–6.
   Google Scholar
• Denzinger S, Fritsche HM, Otto W, et al. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur. Urol. 2008;53(1):146–152.
   PubMed Web of Science ®Google Scholar
• Moschini M, Sharma V, Dell’oglio P, et al. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy. BJU Int. 2016;117(4):604–610.
   PubMed Web of Science ®Google Scholar